Allerotherapeutics
1 known investors
Find your way into Allerotherapeutics
377 people in our graph share verified history with the Allerotherapeutics team — schools, employers, funds. One of them is your warm intro.
Jesper Gromadaunlockedknows Poul Sørensen · together at University of Copenhagen (overlapped)
×6knows the team · via University of Copenhagen
×4knows the team · via Pharmacia & Upjohn
knows the team · via Maxygen, Inc
Allero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease. The company is led by experienced pharmaceutical and biotech executives with deep expertise in immunotherapy R&D and allergen management.
Founders & leadership
EP
Emil PotCEO
FG
Federico GregoCFO
PS
Poul Sørensenin𝕏CSOPoul Sørensen holds a PhD in Biochemistry from Copenhagen University and serves as Chief Scientific Officer at Allerotherapeutics, a biotech company developing immunotherapy solutions for allergy and immune-mediated disorders. He has founded multiple biotech ventures and held leadership roles in R&D, strategy, and business development with focus on inflammation and immunology.
Investors · 1
Frequently asked questions
- What does Allerotherapeutics do?
- Allero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease. The company is led by experienced pharmaceutical and biotech executives with deep expertise in immunotherapy R&D and allergen management.
- Who are Allerotherapeutics's investors?
- Allerotherapeutics's investors include Curie Capital.